Lifecome Biochemistry (002868.SZ) expects a pre-loss, with a projected net loss of 340-390 million yuan in 2024, an increase in losses compared to the previous year.

Lifecome Biochemistry (002868.SZ) announced that it expects a net loss attributable to shareholders of the listed company of 340 million to 390 million yuan in 2024, with a year-on-year increase in losses. It is also expected that the net loss attributable to shareholders of the listed company, after deducting non-recurring gains and losses, will be 345 million to 395 million yuan, with an expanded year-on-year loss.